These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8130923)

  • 1. Carisoprodol as a drug of abuse.
    Rust GS; Hatch R; Gums JG
    Arch Fam Med; 1993 Apr; 2(4):429-32. PubMed ID: 8130923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carisoprodol: a drug of continuing abuse.
    Reeves RR; Pinkofsky HB; Carter OS
    J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carisoprodol: abuse potential and withdrawal syndrome.
    Reeves RR; Burke RS
    Curr Drug Abuse Rev; 2010 Mar; 3(1):33-8. PubMed ID: 20088817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.
    Bramness JG; Furu K; Skurtveit S; Engeland A
    Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carisoprodol: update on abuse potential and legal status.
    Reeves RR; Burke RS; Kose S
    South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abuse of Carisoprodol].
    Lindberg N; Lauerma H
    Duodecim; 1996; 112(2):109-11. PubMed ID: 10590614
    [No Abstract]   [Full Text] [Related]  

  • 9. Abuse of combinations of carisoprodol and tramadol.
    Reeves RR; Liberto V
    South Med J; 2001 May; 94(5):512-4. PubMed ID: 11372804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carisoprodol (Soma): a new and cautious perspective on an old agent.
    Littrell RA; Hayes LR; Stillner V
    South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Carisoprodol Withdrawal After a 14-Year Addiction and Acute Overdose.
    Vo KT; Horng H; Smollin CG; Benowitz NL
    J Emerg Med; 2017 May; 52(5):680-683. PubMed ID: 27979642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
    Toth PP; Urtis J
    Clin Ther; 2004 Sep; 26(9):1355-67. PubMed ID: 15530999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carisoprodol withdrawal after internet purchase.
    Eleid MF; Krahn LE; Agrwal N; Goodman BP
    Neurologist; 2010 Jul; 16(4):262-4. PubMed ID: 20592570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm.
    Ralph L; Look M; Wheeler W; Sacks H
    Curr Med Res Opin; 2008 Feb; 24(2):551-8. PubMed ID: 18194591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carisoprodol abuse: a report from India.
    Sikdar S; Basu D; Malhotra AK; Varma VK; Mattoo SK
    Acta Psychiatr Scand; 1993 Oct; 88(4):302-3. PubMed ID: 8256651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carisoprodol tolerance and precipitated withdrawal.
    Gatch MB; Nguyen JD; Carbonaro T; Forster MJ
    Drug Alcohol Depend; 2012 Jun; 123(1-3):29-34. PubMed ID: 22055010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in carisoprodol abuse and misuse after regulatory scheduling: a retrospective review of California poison control calls from 2008 to 2015.
    Sun C; Hollenbach KA; Cantrell FL
    Clin Toxicol (Phila); 2018 Jul; 56(7):653-655. PubMed ID: 29228807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABA(A) receptors.
    Kumar M; González LA; Dillon GH
    Neuropharmacology; 2015 Oct; 97():414-25. PubMed ID: 25896767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
    Bramness JG; Furu K; Engeland A; Skurtveit S
    Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.